19:10 - 21:00
Room: Ishikawa Ongakudō Interchange Hall
Poster Session
IFN-λ4 attenuates antiviral responses by enhancing negative regulation of IFN signaling
Olusegun O Onabajo1, Adeola A Obajemu1, Nina Rao1, Kari A Dilley2, Faruk Sheikh3, Raymond P Donnelly3, Reed S Shabman2, Ludmila Prokunina-Olsson1
1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States, 2Virology Group, J. Craig Venter Institute, Rockville, United States, 3Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, United States

Type-III interferons (IFNs) are important mediators of antiviral immunity. IFN-λ4 is unique among type-III IFNs because it can be produced only in those individuals who carry a dG allele of a genetic variant rs368234815-TT/dG. Surprisingly, the individuals who can produce IFN-λ4, an antiviral cytokine, are also less likely to clear HCV infection. We aimed to explore unique functional properties of IFN-λ4 that might explain its negative effect on HCV clearance. We used fresh primary human hepatocytes (PHH) treated with recombinant type-III IFNs or infected with Sendai virus (SeV) to model acute viral infection, and subsequently validated our findings in HepG2 cell line models. Endogenous IFN-λ4 protein was detectable only in SeV-infected PHH from individuals with the dG allele; being poorly secreted, IFN-λ4 was highly functional even at concentrations below 50 pg/ml. IFN-λ4 acted faster than other type-III IFNs in inducing antiviral genes as well as negative regulators of IFN response. Transient exposure of PHH to IFN-λ4 but not IFN-λ3 caused a strong and prolonged induction of SOCS1, and IFN-λ4 treated PHH became refractory to further type-III IFN stimulation. Our results suggest unique functional properties of IFN-λ4 that can be important both in viral clearance and other clinical conditions.


Reference:
Mo-P5-2
Session:
Poster Session 5 “Genetic disorders in cytokines and inflammation”
Presenter/s:
Olusegun O Onabajo
Presentation type:
Poster Presentation
Room:
Ishikawa Ongakudō Interchange Hall
Date:
Monday, 30 October 2017
Time:
19:10 - 21:00
Session times:
19:10 - 21:00